Published in PLoS One on June 18, 2015
Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy. Microb Cell Fact (2015) 0.75
SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods (2011) 33.90
The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci U S A (2002) 7.21
Gene splicing and mutagenesis by PCR-driven overlap extension. Nat Protoc (2007) 6.11
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother (2000) 3.08
Prediction of twin-arginine signal peptides. BMC Bioinformatics (2005) 3.03
Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer (2010) 2.70
The twin-arginine translocation (Tat) protein export pathway. Nat Rev Microbiol (2012) 2.53
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A (2010) 2.14
Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol (2010) 2.10
Adaptation of protein secretion to extremely high-salt conditions by extensive use of the twin-arginine translocation pathway. Mol Microbiol (2002) 2.09
The Sec translocase. Biochim Biophys Acta (2010) 2.04
Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane--distinct translocases and mechanisms. Biochim Biophys Acta (2007) 2.03
Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol (2008) 1.99
The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity. PLoS Genet (2009) 1.64
Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther (2000) 1.62
Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol (2009) 1.58
A serpin from the gut bacterium Bifidobacterium longum inhibits eukaryotic elastase-like serine proteases. J Biol Chem (2006) 1.55
Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res (1980) 1.47
Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. Appl Environ Microbiol (2010) 1.41
Characterization of ApuB, an extracellular type II amylopullulanase from Bifidobacterium breve UCC2003. Appl Environ Microbiol (2008) 1.38
High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS One (2012) 1.36
Diversity, ecology and intestinal function of bifidobacteria. Microb Cell Fact (2014) 1.35
The importance of the twin-arginine translocation pathway for bacterial virulence. Trends Microbiol (2008) 1.31
PSORTdb--an expanded, auto-updated, user-friendly protein subcellular localization database for Bacteria and Archaea. Nucleic Acids Res (2010) 1.23
Human milk oligosaccharide consumption by intestinal microbiota. Clin Microbiol Infect (2012) 1.21
Bifidobacterium longum subsp. infantis ATCC 15697 α-fucosidases are active on fucosylated human milk oligosaccharides. Appl Environ Microbiol (2011) 1.20
Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. Mol Ther (2010) 1.11
Comparative genomics of the Bifidobacterium breve taxon. BMC Genomics (2014) 1.07
Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors. Biosci Biotechnol Biochem (2002) 1.05
Bacteria as vectors for gene therapy of cancer. Bioeng Bugs (2011) 1.05
Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther (2003) 1.01
Biomass utilization by gut microbiomes. Annu Rev Microbiol (2014) 1.00
Phytase, a new life for an "old" enzyme. Annu Rev Anim Biosci (2012) 0.98
Complete genome sequence of Bifidobacterium bifidum S17. J Bacteriol (2010) 0.96
Expression of Bacillus subtilis phytase in Lactobacillus plantarum 755. Lett Appl Microbiol (2000) 0.96
Investigation of protein export in Bifidobacterium breve UCC2003. Appl Environ Microbiol (2003) 0.96
Characterization of the serpin-encoding gene of Bifidobacterium breve 210B. Appl Environ Microbiol (2010) 0.96
Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA. Microb Cell Fact (2012) 0.96
Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth. Cancer Gene Ther (2009) 0.95
A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy. Cancer Gene Ther (2006) 0.95
The Tat system of Gram-positive bacteria. Biochim Biophys Acta (2013) 0.92
Selection of phytate-degrading human bifidobacteria and application in whole wheat dough fermentation. Food Microbiol (2007) 0.91
Bacterial vectors for imaging and cancer gene therapy: a review. Cancer Gene Ther (2012) 0.91
Myo-inositol hexakisphosphate degradation by Bifidobacterium infantis ATCC 15697. Int J Food Microbiol (2007) 0.90
Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacol Sin (2005) 0.89
An improved method for a rapid determination of phytase activity in animal feed. J Anim Sci (2005) 0.88
Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model. Vaccine (2010) 0.87
A two-component regulatory system controls autoregulated serpin expression in Bifidobacterium breve UCC2003. Appl Environ Microbiol (2012) 0.87
Factors involved in the colonization and survival of bifidobacteria in the gastrointestinal tract. FEMS Microbiol Lett (2012) 0.87
Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum. Mol Pharm (2011) 0.87
Production of human basic fibroblast growth factor (FGF-2) in Bifidobacterium breve using a series of novel expression/secretion vectors. Biotechnol Lett (2008) 0.85
Bifidobacteria exhibit LuxS-dependent autoinducer 2 activity and biofilm formation. PLoS One (2014) 0.85
Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve. Arch Microbiol (2010) 0.85
Bifidobacteria-host interactions--an update on colonisation factors. Biomed Res Int (2014) 0.85
Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice. Cancer Gene Ther (2011) 0.83
Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice. Int J Obes (Lond) (2010) 0.83
Bacterial-directed enzyme prodrug therapy. J Control Release (2013) 0.82
Bifidobacterium animalis subsp. lactis ATCC 27673 is a genomically unique strain within its conserved subspecies. Appl Environ Microbiol (2013) 0.82
A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum. Biotechnol Lett (2007) 0.81
Expression of fluorescent proteins in bifidobacteria for analysis of host-microbe interactions. Appl Environ Microbiol (2014) 0.81
Therapeutic efficacy of Bifidobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mouse-transplanted tumors. Cancer Sci (2009) 0.79
Novel phytases from Bifidobacterium pseudocatenulatum ATCC 27919 and Bifidobacterium longum subsp. infantis ATCC 15697. Appl Environ Microbiol (2012) 0.79
Bifidobacterium as an oral delivery carrier of interleukin-12 for the treatment of Coxsackie virus B3-induced myocarditis in the Balb/c mice. Int Immunopharmacol (2011) 0.79
High-Quality Draft Genome Sequence of Bifidobacterium longum E18, Isolated from a Healthy Adult. Genome Announc (2013) 0.77
Coexpression and secretion of endoglucanase and phytase genes in Lactobacillus reuteri. Int J Mol Sci (2014) 0.76